🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Cliff Asness’s AKTS Holdings & Trades

First Buy
Q3 2020
Duration Held
7 Quarters
Largest Add
Q2 2024
+95,264 Shares
Current Position
48,123 Shares
$1.55 M Value

Cliff Asness's AKTS Position Overview

Cliff Asness (via Aqr Capital Management LLC) currently holds 48,123 shares of Aktis Oncology, Inc. (AKTS) worth $1.55 M, representing 0.00% of the portfolio. First purchased in 2020-Q3, this short-term holding has been held for 7 quarters.

Based on 13F filings, Cliff Asness has maintained this position in AKTS for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2024, adding 95,264 shares. Largest reduction occurred in Q3 2024, reducing 110,702 shares.

Analysis based on 13F filings available since 2013 Q2

Cliff Asness's Aktis Oncology (AKTS) Holding Value Over Time

Track share changes against reported price movement

Quarterly Aktis Oncology (AKTS) Trades by Cliff Asness

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q2 2026 +48,123 New Buy 48,123 $32.23
Q3 2024 -110,702 Sold Out 0 $0.00
Q2 2024 +95,264 Add 617.07% 110,702 $0.13
Q1 2024 -23,520 Reduce 60.37% 15,438 $0.59
Q4 2023 +38,958 New Buy 38,958 $0.83
Q4 2020 -12,077 Sold Out 0 $0.00
Q3 2020 +12,077 New Buy 12,077 $8.20

Cliff Asness's Aktis Oncology Investment FAQs

Cliff Asness first purchased Aktis Oncology, Inc. (AKTS) in Q3 2020, acquiring 12,077 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Cliff Asness has held Aktis Oncology, Inc. (AKTS) for 7 quarters since Q3 2020.

Cliff Asness's largest addition to Aktis Oncology, Inc. (AKTS) was in Q2 2024, adding 110,702 shares worth $14,579.

According to the latest 13F filing for Q2 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 48,123 shares of Aktis Oncology, Inc. (AKTS), valued at approximately $1.55 M.

As of the Q2 2026 filing, Aktis Oncology, Inc. (AKTS) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.

Cliff Asness's peak holding in Aktis Oncology, Inc. (AKTS) was 110,702 shares, as reported at the end of Q2 2024.